Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Current Period Unaudited)

v3.22.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 9,040 $ 8,137
Accounts receivable 435 269
Lease receivable, current portion 1,019 920
Inventory 45 123
Assets held for sale 1,100 2,633
Prepaid expenses and other current assets 427 356
Total current assets 12,066 12,438
Non-current assets    
Property and equipment, net 2,780 2,367
Intellectual property, net 595 640
Investment in LINICO 2,000 1,500
Lease receivable, non-current portion 15,244 15,528
Other assets 887 796
Total non-current assets 21,506 20,831
Total assets 33,572 33,269
Current liabilities    
Accounts payable 1,025 685
Accrued expenses 2,889 3,005
Lease liability, current portion 282 388
Total current liabilities 4,196 4,078
Building purchase deposit 1,250 1,328
Lease liability, non-current portion 508 330
Total liabilities 5,954 5,736
Commitments and contingencies
Stockholders’ equity    
Common stock; $0.001 par value; 100,000,000 shares authorized; 74,934,199 and 70,416,552 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 75 70
Additional paid-in capital 215,799 211,309
Accumulated deficit (188,256) (183,846)
Total stockholders’ equity 27,618 27,533
Total liabilities and stockholders’ equity $ 33,572 $ 33,269